The Activation of the AMPK–Pdlim5 Pathway Is Involved in the Protective Function of Metformin Against Diabetes-Accelerated Atherosclerosis in ApoE–/– Mice. This evidence concerns the gene PRKAA1 and diabetes mellitus.